Phase 2 Results for EP-101 Positive - Drug Discovery & Development

Phase 2 Results for EP-101 Positive Drug Discovery & Development ... with respiratory diseases, announced positive results from a Phase 2b study of EP-101 in patients with chronic obstructive pulmonary disease (COPD), a progressive disease comprising chronic bronchitis and emphysema caused largely by smoking. and more »

Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for ... - MarketWatch (press release)

Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for ... MarketWatch (press release) Patients experienced a robust magnitude and duration of bronchodilation comparable to the active comparators, a rapid onset of action (approximately 5 minutes), and a fast treatment time of less than 3 minutes as delivered via the eFlow nebulizer. and more »

Lung Disease Following Deployment in Iraq and Afghanistan - news Stories

news Stories

Lung Disease Following Deployment in Iraq and Afghanistan news Stories 3 Subsequent epidemiologic studies showed that deployers have higher rates of newly reported respiratory symptoms than nondeployers (14% versus 10%), although rates of physician-diagnosed asthma and chronic bronchitis were not increased.

Targeted Therapies in the Management of Leukemia and Lymphoma - Cancer Network

Targeted Therapies in the Management of Leukemia and Lymphoma Cancer Network [2] The reported response rate was 48%, with 6% complete responses (CRs) and a median duration of response of about 1 year. Subsequent studies confirmed its effectiveness as a single agent in both the upfront and refractory disease settings. and more »

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal ... - MarketWatch (press release)

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal ... MarketWatch (press release) ... cough, influenza, bronchitis, streptococcal pharyngitis, muscle strain, and nausea. Nasal discomfort (5.7%) and epistaxis (11.4%) were also more frequent in the 26 week trial compared to clinical trials 2 to 6 weeks in duration. and more »